{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:31:04Z","timestamp":1786336264793,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic inflammation plays an important role in tumor development and progression. Several inflammation-related indices derived from routine blood tests have been proposed as potential biomarkers for cancer. However, their associations with gastrointestinal tumors in large population-based datasets remain insufficiently explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the National Health and Nutrition Examination Survey (NHANES) were used to examine the associations between nine systemic inflammatory indices and gastrointestinal tumors. Multivariable logistic regression, propensity score matching, and restricted cubic spline analyses were performed. Mortality-linked NHANES data were further analyzed using Cox regression and Kaplan\u2013Meier methods. An independent hospital-based cohort was used to validate the main findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Several systemic inflammatory indices were significantly associated with gastrointestinal tumor status in NHANES. NLR and RAR showed particularly strong associations and ranked among the most influential variables in the machine-learning analyses. Restricted cubic spline analyses indicated nonlinear association patterns, with higher NLR and RAR levels corresponding to greater odds of gastrointestinal tumors. The main findings remained generally consistent in the propensity score-matched cohort. In the hospital-based cohort, patients with gastrointestinal tumors also showed higher systemic inflammatory levels than healthy controls. A nomogram incorporating CALLY, NLR, RAR, and clinical variables demonstrated good discriminative performance, with an AUC of 0.852. In addition, several baseline inflammatory indices were independently associated with all-cause mortality among patients with gastrointestinal tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Systemic inflammatory indices derived from routine blood tests were associated with gastrointestinal tumor status and all-cause mortality. These main findings were further supported by the hospital-based cohort. Routine inflammation-related indices may therefore provide useful information for identifying tumor-associated inflammatory changes and evaluating prognosis in patients with gastrointestinal tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1886964","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:23:03Z","timestamp":1786335783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of systemic inflammatory indices with gastrointestinal tumors: evidence from NHANES and a hospital-based cohort"],"prefix":"10.3389","volume":"13","author":[{"given":"Rui","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The First People's Hospital of Hefei","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifen","family":"Ji","sequence":"additional","affiliation":[{"name":"Medical Pathology Center, Hefei Cancer Hospital, Chinese Academy of Sciences","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First People's Hospital of Hefei","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First People's Hospital of Hefei","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First People's Hospital of Hefei","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1016\/j.cgh.2023.01.037","volume":"21","author":"Rustgi","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/gutjnl-2024-333227","article-title":"Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021","volume":"74","author":"Danpanichkul","year":"2024","journal-title":"Gut."},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12889-024-21192-3","volume":"25","author":"Jiang","year":"2025","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/cac2.70017","article-title":"Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades","volume":"45","author":"Li","year":"2025","journal-title":"Cancer Commun (Lond)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-025-01698-y","article-title":"The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis","volume":"18","author":"Chen","year":"2025","journal-title":"J Hematol Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/s12885-025-14204-x","article-title":"Exploring the potential of machine learning in gastric cancer: prognostic biomarkers, subtyping, and stratification","volume":"25","author":"Rafiepoor","year":"2025","journal-title":"BMC Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1690200","DOI":"10.3389\/fimmu.2025.1690200","article-title":"Deep learning and multi-omics reveal programmed cell death-associated diagnostic signatures and prognostic biomarkers in gastric cancer","volume":"16","author":"Jin","year":"2025","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells."},{"key":"B9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","article-title":"Inflammation in cancer: therapeutic opportunities from new insights","volume":"24","author":"Xie","year":"2025","journal-title":"Mol Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/cells14080567","article-title":"Inflammation-associated carcinogenesis in inflammatory bowel disease: clinical features and molecular mechanisms","volume":"14","author":"Hisamatsu","year":"2025","journal-title":"Cells."},{"key":"B11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/antiox14060735","article-title":"Oxidative stress and inflammation: drivers of tumorigenesis and therapeutic opportunities","volume":"14","author":"Wang","year":"2025","journal-title":"Antioxidants (Basel)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratisl Lek Listy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00423-023-02786-8","article-title":"Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis","volume":"408","author":"Portale","year":"2023","journal-title":"Langenbecks Arch Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1321584","DOI":"10.3389\/fimmu.2023.1321584","article-title":"Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"14","author":"Mei","year":"2023","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","article-title":"Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review","volume":"24","author":"Islam","year":"2024","journal-title":"Turk J Emerg Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1040163","DOI":"10.3389\/fphar.2022.1040163","article-title":"Chronic inflammation, cancer development and immunotherapy","volume":"13","author":"Wen","year":"2022","journal-title":"Front Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13167-019-00194-x","article-title":"Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles","volume":"10","author":"Qian","year":"2019","journal-title":"EPMA J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/antiox12040901","article-title":"Oxidative stress, inflammation and colorectal cancer: an overview","volume":"12","author":"Bardel\u010d\u00edkov\u00e1","year":"2023","journal-title":"Antioxidants (Basel)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1158\/2159-8290.CD-22-1220","article-title":"The DNA damage response and inflammation in cancer","volume":"13","author":"Klapp","year":"2023","journal-title":"Cancer Discov."},{"key":"B21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","article-title":"Inflammation: the incubator of the tumor microenvironment","volume":"8","author":"Denk","year":"2022","journal-title":"Trends Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-981-99-4657-0_2","article-title":"Cytokines and chemokines in tumor growth and progression","author":"Mir","year":"2023","journal-title":"Cytokine and Chemokine Networks in Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s42003-021-02376-8","article-title":"Neutrophil-derived reactive oxygen species promote tumor colonization","volume":"4","author":"Zhong","year":"2021","journal-title":"Commun Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e006462","DOI":"10.1136\/jitc-2022-006462","article-title":"Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunity","volume":"11","author":"Zheng","year":"2023","journal-title":"J Immunother Cancer."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1100453","DOI":"10.3389\/fendo.2023.1100453","article-title":"Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study","volume":"14","author":"Song","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/biom13121803","article-title":"Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, gastrointestinal, and other solid tumors: immunotherapy and beyond","volume":"13","author":"Mosca","year":"2023","journal-title":"Biomolecules."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9146042","DOI":"10.1155\/2020\/9146042","article-title":"Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer","volume":"2020","author":"Fang","year":"2020","journal-title":"J Immunol Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00432-023-05508-1","article-title":"Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer","volume":"150","author":"Zhang","year":"2024","journal-title":"J Cancer Res Clin Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3610038","DOI":"10.1155\/2022\/3610038","article-title":"Prognostic value of lymphocyte-to-monocyte ratio (LMR) in cancer patients undergoing immune checkpoint inhibitors","volume":"2022","author":"Wan","year":"2022","journal-title":"Dis Markers."},{"key":"B30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12876-025-03871-6","article-title":"Association between the red blood cell distribution width-to-albumin ratio and risk of colorectal and gastric cancers: a cross-sectional study using NHANES 2005-2018","volume":"25","author":"Luo","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3390\/ijms23116022","article-title":"An insight into recent advances on platelet function in health and disease","volume":"23","author":"Chaudhary","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.trecan.2021.01.012","article-title":"Liver Inflammation and Hepatobiliary Cancers","volume":"7","author":"Leone","year":"2021","journal-title":"Trends Cancer."},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-03503-6_8","article-title":"Chronic inflammation and hepatocellular carcinoma","volume-title":"Inflammation and Gastrointestinal Cancers","author":"Alison","year":"2011"},{"key":"B35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/cancers15030761","article-title":"Pancreatic cancer in chronic pancreatitis: pathogenesis and diagnostic approach","volume":"15","author":"Le Cosquer","year":"2023","journal-title":"Cancers (Basel)."},{"key":"B36","doi-asserted-by":"publisher","first-page":"102268","DOI":"10.1016\/j.canep.2022.102268","article-title":"The validity of self-reported cancer in a population-based cohort compared to that in formally registered sources","volume":"81","author":"Cort\u00e9s-Ib\u00e1\u00f1ez","year":"2022","journal-title":"Cancer Epidemiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1886964\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:23:04Z","timestamp":1786335784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1886964\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":36,"alternative-id":["10.3389\/fmed.2026.1886964"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1886964","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1886964"}}